U.S. Food and Drug Administration issues Complete Response Letter for Ulipristal Acetate New Drug Application
8/22/2018
Business related Regulatory Marketing authorization application postponed Women's Healthcare PARTNER - ALLERGAN / ABBVIE / ACTAVIS API - ULIPRISTAL ACETATE